Table 1.

Demographic data of the participants.

Age, years, mean (SD)	65.7 (10.6)
Sex, female/male, n (%)	237 (50.3)/234 (49.7)
Body height, cm, mean (SD)	159.9 (10.6)
Body weight, kg, mean (SD)	57.1 (40.8)
Body mass index, mean (SD)	22.2 (14.2)
Duration of disease, years, mean (SD)	12.1 (7.5)
Duration of medication, years, means (SD)	10.4 (8.2)
Hoehn and Yahr stage, median (IQR)	2.0 (1)
MDS-UPDRS part III, median (IQR)	22.0 (18.5)
Barthel Index, median (IQR)	80.0 (30.0)
Mini-BESTest total score, median (IQR)	19.0 (10.0)
Deep brain stimulation setting
Pulse, microseconds, mean (SD)	54.9 (19.2)
Hz, mean (SD)	130.4 (40.1)
mA, mean (SD)	2.5 (0.9)
LDD, mg, mean (SD)	636.4 (947.8)
LEDD, mg, mean (SD)	283.5 (496.0)

Data are mean (SD), n (%), or median (IQR) values. SD, standard deviation; IQR, interquartile range; MDS-UPDRS, movement disorders society-unified Parkinson’s disease rating scale; Mini-BESTest, Mini-Balance Evaluation Systems Test; LDD, levodopa daily dose; LEDD, levodopa equivalent daily dose.